Shares of Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) rose 68.6% during mid-day trading on Monday . The company traded as high as $0.59 and last traded at $0.59. Approximately 102 shares changed hands during trading, a decline of 89% from the average daily volume of 971 shares. The stock had previously closed at $0.35.
Orgenesis Trading Up 68.6%
The company has a 50 day moving average price of $0.27 and a 200 day moving average price of $0.36. The firm has a market cap of $3.05 million, a PE ratio of -0.05 and a beta of 3.16.
About Orgenesis
Orgenesis, Inc is a cell and gene therapy company that develops and commercializes point-of-care manufacturing platforms for autologous and allogeneic therapies. The company offers an end-to-end solution that spans from R&D through clinical and commercial production, targeting applications in oncology, neurology, and various rare diseases. Orgenesis’ technology platforms are designed to streamline the complex processes involved in cell isolation, genetic modification, expansion and cryopreservation.
The company’s flagship offering is its automated Prodigy® platform, which integrates cell processing workflows into a closed, single-use system.
Further Reading
- Five stocks we like better than Orgenesis
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
